Clinical Scorecard: Patterns of Medication Initiation, Discontinuation, and Adherence in ADHD Among Norwegian Youth: A Population-Based Register Analysis
At a Glance
Category
Detail
Condition
Attention-Deficit/Hyperactivity Disorder (ADHD)
Key Mechanisms
Medication initiation, discontinuation, and adherence patterns
Target Population
Children and adolescents diagnosed with ADHD (aged <18 years)
Care Setting
Child and adolescent mental health services
Key Highlights
74.3% of the cohort initiated ADHD medication within a median of 106 days post-diagnosis.
Discontinuation rates increased significantly with age, particularly in adolescents aged 15-17 years.
Females discontinued ADHD medication significantly earlier than males.
Older age at initiation and female sex were associated with a steeper decline in medication adherence over time.
Only 47% of adolescents continued their ADHD medication one year after initiation.
Guideline-Based Recommendations
Diagnosis
ADHD diagnosis should be made in child and adolescent mental health services.
Management
Pharmacological interventions, particularly stimulant medications, are first-line treatments.
Monitoring & Follow-up
Closer clinical monitoring is recommended for older adolescents and females to support treatment continuation.
Risks
Premature treatment cessation may lead to adverse outcomes including re-emergence of ADHD symptoms.
Patient & Prescribing Data
Children and adolescents diagnosed with ADHD in Norway.
Medication adherence is critically dependent on consistent use, with high rates of discontinuation observed.
Clinical Best Practices
Integrate structured transition planning for adolescents.
Address sex-specific barriers to adherence.
Utilize shared decision-making to support informed discontinuation.
